[1]
Gawęda, W. et al. 2026. THE CLINICAL UTILITY OF PRESEPSIN (sCD14-ST) AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN SEPSIS: A COMPREHENSIVE REVIEW. International Journal of Innovative Technologies in Social Science. 4, 3(51) (Sep. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.6719.